Abstract:Glioma is the most common and aggressive primary adult brain tumor. Radiation therapy (RT) is a critical part of glioma treatment, but radioresistance severely limits its therapeutic efficacy. To better understand how radioresistance develops, we analyzed 212 paired primary and recurrent gliomas from the Glioma Longitudinal Analysis Consortium. We found a significant increase in mutational signatures associated with the activity of the Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) family of cytidine deaminases in RT-treated recurrent gliomas (p<0.001, paired Wilcoxon signed-rank test). Further analysis of post-treatment mutations showed that RT increased APOBEC mutational signatures independent of other factors (p<0.001, multivariable log-linear regression), suggesting that APOBEC proteins become activated by radiation. However, their role in promoting tumor evolution and treatment resistance is currently unknown. Further analyses of extended signature contexts and expression data nominated APOBEC3B (A3B) and APOBEC3G (A3G) as candidates for creating these mutational signatures. To investigate their roles in RT response, we knocked out (KO) A3B and A3G individually in patient-derived glioma cell lines before RT. Compared to Control cells, irradiated A3B-KO and A3G-KO cells acquired significantly fewer APOBEC mutational signatures by whole genome sequencing (p<0.05, Kruskal–Wallis test) and exhibited enhanced radiosensitivity in vitro . Interestingly, the KO cells displayed a significant decrease in mutational signatures associated with Non-Homologous End-Joining (NHEJ), one of the main pathways for repairing the RT-induced DNA damage (p<0.05, Kruskal–Wallis test), suggesting that APOBEC deletion impaired DNA repair. This was further supported by persistent gH2AX DNA damage foci 48h post-RT and reduced autophosphorylation of DNA-dependent protein kinase (DNA-PK), a vital component of the NHEJ pathway, particularly in A3G KO cells. Overall, our results identify APOBEC proteins as potential targets for radiosensitizing gliomas and highlight the clinical utility of using mutational signatures to predict and monitor response to treatment.

AEG-1 Knockdown Sensitizes Glioma Cells to Radiation Through Impairing Homologous Recombination Via Targeting RFC5

AEG-1 silencing attenuates M2-polarization of glioma-associated microglia/macrophages and sensitizes glioma cells to temozolomide

Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells

AEG-1 Expression Correlates with CD133 and PPP6c Levels in Human Glioma Tissues.

Progress in Treatment for Malignant Tumors with Astrocyte Elevated Gene-1

LRIG 1 Enhances the Radiosensitivity of Radioresistant Human Glioblastoma U 251 Cells Via Attenuation of the EGFR / Akt Signaling Pathway

Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification

The AEG-1-USP10-PARP1 Axis Confers Radioresistance in Esophageal Squamous Cell Carcinoma Via Facilitating Homologous Recombination-Dependent DNA Damage Repair.

Knockdown of Astrocyte Elevated Gene-1 Inhibits Tumor Growth and Modifies Micrornas Expression Profiles in Human Colorectal Cancer Cells.

AEG-1 Expression Characteristics in Human Non-Small Cell Lung Cancer and Its Relationship with Apoptosis

Knockdown of ATRX enhances radiosensitivity in glioblastoma

Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

Dnar-16. Targeting Apobec Cytidine Deaminases To Enhance Radiosensitivity In Glioma

Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.

Cofilin-1 and Phosphoglycerate Kinase-1 Up Regulated the Radiation Resistance in Primary Human Glioma Cells

Combination Therapy with Gamma Knife Radiosurgery and Antisense EGFR for Malignant Glioma in Vitro and Orthotopic Xenografts.

TGF-β/Smads Signaling Affects Radiation Response and Prolongs Survival by Regulating DNA Repair Genes in Malignant Glioma.

Astrocyte elevated gene 1: biological functions and molecular mechanism in cancer and beyond

AEG-1/MTDH-activated Autophagy Enhances Human Malignant Glioma Susceptibility to TGF-β1-triggered Epithelial-Mesenchymal Transition

Downregulation of Astrocyte Elevated Gene-1 Expression Combined with All-Trans Retinoic Acid Inhibits Development of Vasculogenic Mimicry and Angiogenesis in Glioma.

Phosphoglycerate Kinase 1 Promotes Radioresistance in U251 Human Glioma Cells.